These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21825843)

  • 1. Iodine-123 metaiodobenzylguanidine cardiac imaging as a method to detect early sympathetic neuronal dysfunction in chagasic patients with normal or borderline electrocardiogram and preserved ventricular function.
    Landesmann MC; da Fonseca LM; de B Pereira B; do Nascimento EM; Rosado-de-Castro PH; de Souza SA; de S L Lima R; Pedrosa RC
    Clin Nucl Med; 2011 Sep; 36(9):757-61. PubMed ID: 21825843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodine 123-metaiodobenzylguanidine imaging reflect generalized sympathetic activation in patients with left ventricular dysfunction.
    Yuyama R; Yuasa F; Hikosaka M; Mimura J; Kawamura A; Hatada K; Motohiro M; Iwasaki M; Sugiura T; Iwasaka T
    Clin Physiol Funct Imaging; 2005 Jan; 25(1):34-9. PubMed ID: 15659078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability.
    Delahaye N; Dinanian S; Slama MS; Mzabi H; Samuel D; Adams D; Merlet P; Le Guludec D
    Eur J Nucl Med; 1999 Apr; 26(4):416-24. PubMed ID: 10199949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of aging on cardiac sympathetic innervation measured by
    Rengo G; Pagano G; Vitale DF; Formisano R; Komici K; Petraglia L; Parisi V; Femminella GD; de Lucia C; Paolillo S; Cannavo A; Attena E; Pellegrino T; Dellegrottaglie S; Memmi A; Trimarco B; Cuocolo A; Filardi PP; Leosco D; Ferrara N
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2392-2400. PubMed ID: 27287990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy.
    Miranda CH; Figueiredo AB; Maciel BC; Marin-Neto JA; Simões MV
    J Nucl Med; 2011 Apr; 52(4):504-10. PubMed ID: 21441532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy.
    Shimizu M; Ino H; Yamaguchi M; Terai H; Hayashi K; Nakajima K; Taki J; Mabuchi H
    J Nucl Med; 2002 Jan; 43(1):15-20. PubMed ID: 11801697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine-123 metaiodobenzylguanidine myocardial imaging in haemodialysed patients asymptomatic for coronary artery disease: a preliminary report.
    Chrapko BE; Jaroszyński AJ; Głowniak A; Bednarek-Skublewska A; Załuska W; Ksiażek A
    Nucl Med Commun; 2011 Jun; 32(6):515-21. PubMed ID: 21427625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.
    Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
    J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiac sympathetic innervation in patients with ventricular arrhythmias: an assessment by 123I-metaiodobenzylguanidine scintigraphy].
    Loladze NV; Golitsyn SP; Samoĭlenko LE; Bekbosynova MS; Novikova DS; Nikitina DS; Nikitina TIa; Sergienko VB
    Kardiologiia; 2006; 46(5):27-34. PubMed ID: 16858351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction.
    Matsunari I; Aoki H; Nomura Y; Takeda N; Chen WP; Taki J; Nakajima K; Nekolla SG; Kinuya S; Kajinami K
    Circ Cardiovasc Imaging; 2010 Sep; 3(5):595-603. PubMed ID: 20534790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of 123I-metaiodobenzylguanidine myocardial scintigram in patients with valvular heart disease].
    Terada K; Sugihara H; Shiga K; Ohtsuki K; Ito K; Taniguchi Y; Azuma A; Kohno Y; Miyao K; Nakagawa M
    J Cardiol; 1995 May; 25(5):247-53. PubMed ID: 7776194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123)I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease.
    Spinelli L; Pellegrino T; Pisani A; Giudice CA; Riccio E; Imbriaco M; Salvatore M; Trimarco B; Cuocolo A
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):729-39. PubMed ID: 26639748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The heterogeneity of myocardial sympathetic innervation in normal subjects: an assessment by iodine-123 metaiodobenzylguanidine scintigraphy].
    D'Alto M; Maurea S; Basso A; Varrella P; Polverino W; Bianchi U; Bonelli A; Salvatore M; Chiariello M
    Cardiologia; 1998 Nov; 43(11):1231-6. PubMed ID: 9922590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients.
    Boogers MJ; Borleffs CJ; Henneman MM; van Bommel RJ; van Ramshorst J; Boersma E; Dibbets-Schneider P; Stokkel MP; van der Wall EE; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2010 Jun; 55(24):2769-77. PubMed ID: 20538172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac sympathetic nervous system in early essential hypertension assessed by 123I-MIBG.
    Sakata K; Shirotani M; Yoshida H; Kurata C
    J Nucl Med; 1999 Jan; 40(1):6-11. PubMed ID: 9935049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic nervous function in patients with hypertrophic cardiomyopathy assessed by [123I]-MIBG: relationship with left ventricular perfusion and function.
    Pace L; Betocchi S; Losi MA; Della Morte AM; Ciampi Q; Nugnez R; Chiariello M; Salvatore M
    Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):20-5. PubMed ID: 15195000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study.
    Bax JJ; Kraft O; Buxton AE; Fjeld JG; Parízek P; Agostini D; Knuuti J; Flotats A; Arrighi J; Muxi A; Alibelli MJ; Banerjee G; Jacobson AF
    Circ Cardiovasc Imaging; 2008 Sep; 1(2):131-40. PubMed ID: 19808530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT interval variability in type 2 diabetic patients with cardiac sympathetic dysinnervation assessed by 123I-metaiodobenzylguanidine scintigraphy.
    Sacre JW; Franjic B; Coombes JS; Marwick TH; Baumert M
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):305-13. PubMed ID: 23210722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.
    Wakabayashi T; Nakata T; Hashimoto A; Yuda S; Tsuchihashi K; Travin MI; Shimamoto K
    J Nucl Med; 2001 Dec; 42(12):1757-67. PubMed ID: 11752070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.